HIGHLIGHTS
- who: Prostate Cancer via MYBL and colleagues from the Department of Urology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui, China have published the Article: LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis, in the Journal: Oxidative Medicine and Cellular Longevity of 22/02/2022
- what: The authors showed that MYBL2 is a downstream target of MALAT1.
- how: The authors examined the products of metabolism which were compared between MYBL2 knockdown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.